Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000145870 | SCV000193007 | benign | not specified | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000145870 | SCV000714314 | benign | not specified | 2017-01-24 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV002316929 | SCV000850132 | likely benign | Inborn genetic diseases | 2016-08-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000878238 | SCV001021104 | benign | not provided | 2023-12-12 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000878238 | SCV005206716 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000145870 | SCV001928872 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000878238 | SCV001971808 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003975145 | SCV004800638 | benign | DCX-related disorder | 2019-05-14 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |